PDL BioPharma (PDLI) Releases Q2 Revenue Guidance at $128 Million
Tweet Send to a Friend
PDL BioPharma, Inc. (NASDAQ: PDLI) today announced revenue guidance for the second ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE